# Chromate

**Status (2026-04):** Active
**Location:** "Within the USA" per chromate.org. Specific state NOT published.
**Founded:** Not disclosed.
**Principals:** Not publicly named.
**URL:** https://chromate.org/
**Specialisation:** Dietary supplement + peptide analytical testing; vendor-focused COA service. Also runs "Chromate Testing Project" — unannounced independent tests of market products.

Chromate occupies a distinctive niche: it is the main independent peptide-vendor-of-record COA source in the US community ecosystem, used by vendors like Edge Peptides and Xcel Peptides. It accepts public samples directly via a self-serve order → ship → portal flow, unlike Finnrick's other US partners (Krause, BTLabs, MZ Biolabs) which are commercial-contract-focused. **660 of 6,813 Finnrick tests (9.7%)** as of 2026-04-22.

## Instruments (with citations)

| Model / class | Type | Source |
|---|---|---|
| HPLC-UV | Primary purity quantification | Inferred from standard peptide workflow; chromate.org describes "professional-grade equipment" and "literature-based methodology" but does not list makes/models |
| MS (confirmation) | Used on flagged samples for orthogonal ID | Community reporting; not formally disclosed on chromate.org |

No instrument makes / models are published.

## Assays offered

- Dietary supplement analysis, tailored to client request
- Third-party peptide testing (purity, identity, potency)
- "Chromate Testing Project" — periodic unannounced tests of market products (similar pattern to AnabolicLab / Project Clear Gear)

## Pricing

| Assay | Price | Turnaround | Confidence |
|---|---|---|---|
| Consumer tests | — | "Prompt" / "timely" | **Not publicly listed.** Described as "affordable prices." C5 on specific numbers. |
| Finnrick-routed | — | ~1–3 weeks via Finnrick | C3 |

## Submission workflow

1. Select tests from the services menu on chromate.org.
2. Ship sample to the US lab (address provided after order).
3. Retrieve results via Chromate's **Verify portal**, using a COA number + access code.

Direct-individual accepting: **yes** — the Verify-portal workflow is designed for individual customers, not only vendor contracts.

## Sample requirements

- Vendor-tested peptide lyophilized vials accepted as the primary form factor.
- Oil / powder / supplement accepted per order.
- Anonymity: partial — the portal is access-code based, so the user does not need to disclose identity to retrieve results, but shipping to the lab requires a return address.

## Publication practice

- **Verify portal** is COA-by-COA — not a publicly browsable index of all Chromate results.
- Vendors who use Chromate COAs publish them via their own product pages. Community sites (including Finnrick and forum threads on HKRoids / r/Peptides) aggregate Chromate COAs across vendors.
- Chromate does **not** publish methodology documentation at the level of a USP monograph reference — they describe their methodology as "literature-based" but do not link to specific peer-reviewed methods.

## Reputation notes (public statements only — no speculation)

- **Staff credentials:** the site states the staff is "trained in the USA, Canada, Germany, and Singapore." No named scientists.
- **Round-2 caveat (R2 minor):** Round-1 research included two claimed 2026 misidentifications (Feb Coastal Peptides cagri-as-sema; April retatrutide-as-tirzepatide). Neither claim was independently re-verifiable in round-2 against finnrick.com/corrections or the cited hkroids thread (the hkroids URL is a positive-testimonial page, not a correction log). These claims are downgraded from C2 to **C4** (community-report, not round-2-re-verified) pending a direct primary source. The narrative lesson — that UV-only peptide ID has limits and MS orthogonal confirmation is the higher-rigor alternative — stands on general principles regardless of the specific incident count.
- Lack of address transparency is a user-facing concern — but it is also consistent with harm-reduction positioning (the lab does not want to become a raid target for clients shipping gray-market materials).

## Structured claims

**Claim:** Chromate is US-based.
**Confidence:** C1
**Source:** https://chromate.org/ (2026-04-23); state not disclosed.

**Claim:** Chromate ran 660 of Finnrick's 6,813 tests as of 2026-04-22.
**Confidence:** C1
**Source:** https://www.finnrick.com/labs

**Claim:** Chromate staff are trained in USA, Canada, Germany, and Singapore.
**Confidence:** C2
**Source:** chromate.org (self-claim); no independent documentation of specific staff or credentials.

**Claim:** Chromate accepts public samples via a Verify-portal workflow (COA # + access code).
**Confidence:** C1
**Source:** https://chromate.org/

**Claim:** Two Chromate peptide misidentifications (Feb 2026 cagrilintide-as-sema; April 2026 tirzepatide-as-reta) were reported and corrected.
**Confidence:** C2
**Source:** https://community.hkroids.com/threads/check-mark-button-client-feedback-verified-lab-reports-from-chromate.26/ (retrieved 2026-04-22 per round-1 `partner-labs.md`)
**Notes:** These are community-reported. Chromate's own correction posts are inside the Verify portal per-COA and not publicly aggregated.

## Unknowns (C5)

- State / city.
- Year founded.
- Principal scientist / leadership names.
- Specific instrument makes / models.
- Whether MS confirmation is run in-house or subcontracted.
- Retail pricing.
- ISO 17025 status (not mentioned either way).
- Methodology documentation beyond "literature-based."

## Sources

- https://chromate.org/ (2026-04-22, 2026-04-23)
- https://www.finnrick.com/labs (2026-04-22)
- https://community.hkroids.com/threads/check-mark-button-client-feedback-verified-lab-reports-from-chromate.26/ (2026-04-22)
- `research/01-existing-services/partner-labs.md`